{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:20:57Z","timestamp":1789662057158,"version":"4.0.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ajem.2019.09.011","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T02:17:35Z","timestamp":1578449855000},"page":"690.e1-690.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Meropenem as an antidote for intentional valproic acid overdose"],"prefix":"10.1016","volume":"38","author":[{"given":"Caitlin","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Priano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2019.09.011_bb0005","series-title":"Depakote (divalproex sodium) [package insert]","year":"2011"},{"issue":"5","key":"10.1016\/j.ajem.2019.09.011_bb0010","first-page":"185","article-title":"Recognizing and treating valproic acid toxicity: a case report","volume":"2","author":"Crudup","year":"2011","journal-title":"J Med Case"},{"key":"10.1016\/j.ajem.2019.09.011_bb0015","series-title":"Meropenem [package insert]","year":"2018"},{"key":"10.1016\/j.ajem.2019.09.011_bb0020","first-page":"1","article-title":"Valproate interaction with carbapenems: review and recommendations","author":"Al-Quteimat","year":"2019","journal-title":"Hosp Pharm"},{"issue":"2","key":"10.1016\/j.ajem.2019.09.011_bb0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00498254.2015.1054002","article-title":"In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs","volume":"46","author":"Suzuki","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ajem.2019.09.011_bb0030","first-page":"1","article-title":"Intentional use of carbapenem antibiotics for valproic acid toxicity: a case report","volume":"0","author":"Khobrani","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ajem.2019.09.011_bb0035","doi-asserted-by":"crossref","unstructured":"Wu CC, Pai TY, Hsiao FY, et al. The effect of different carbapenem antibiotics (ertapenem, imipenem\/cilastatin, and meropenem) on serum valproic acid concentrations. Ther Drug Monit Ther Drug Monit;38:587\u2013592.","DOI":"10.1097\/FTD.0000000000000316"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675719306217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675719306217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:47:04Z","timestamp":1760024824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675719306217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0735675719306217"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2019.09.011","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meropenem as an antidote for intentional valproic acid overdose","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}